CAMBRIDGE, Mass., Apr 25, 2012 (BUSINESS WIRE) --ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
host a live webcast of its quarterly conference call at 8:30 a.m. (ET)
on Wednesday, May 9, 2012. Harvey J. Berger, M.D., chairman and chief
executive officer, will host the call. ARIAD senior management will
discuss the Company's financial results as of March, 31, 2012, as well
as key corporate objectives and additional corporate activities. The
Company will announce highlights of these topics in a press release to
be issued before the market opens on May 9, 2012 prior to the conference
call.
The live webcast can be accessed by visiting the investor relations
section of the Company's website at http://investor.ariad.com.
The call can be accessed by dialing 800-260-8140 (domestic) or 617
-614-3672 (international) five minutes prior to the start time and
providing the pass code 33704570. A replay of the call will be available
on the ARIAD website approximately two hours after completion of the
call and will be archived for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD's approach to
structure-based drug design has led to three internally discovered,
molecularly targeted product candidates for drug-resistant or
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia, soft tissue and bone sarcomas and non-small cell lung cancer.
For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter.
SOURCE: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
For Investors
Maria E.
Cantor, (617) 621-2208
Maria.cantor@ariad.com
or
For
Media
Lynn Granito, (212) 253-8881
lgranito@berrypr.com
